Saliva and inhibition of HIV-1 infection: molecular mechanisms

被引:38
作者
Shugars, DC
Sweet, SP
Malamud, D
Kazmi, S
Page-Shafer, K
Challacombe, SJ
机构
[1] Univ N Carolina, Sch Dent, Dept Dent, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Dent, Dept Med, Chapel Hill, NC USA
[3] Guys Hosp, Dept Oral Med Pathol Microbiol & Immunol, London SE1 9RT, England
[4] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA
[5] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent, San Francisco, CA USA
关键词
HIV; antiviral; saliva; transmission; mucosal immunity; antibody testing;
D O I
10.1034/j.1601-0825.8.s2.7.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Oral fluids are rarely a vehicle for HIV-1 infection in vivo, unlike other mucosal secretions. This unique property raises questions regarding (1) the molecular mechanisms responsible for the lack of salivary transmission, (2) the extent to which oral immunological responses mirror responses at other mucosal sites, (3) the use of promising salivary markers of HIV-1 disease progression, (4) the relationship between oral and blood viral loads, (5) cofactors that influence oro-genital transmission, and (6) the feasibility of oral-based antibody testing for HIV-1 diagnosis in the home. This paper discusses these questions and provides background summaries, findings from new studies, consensus opinions, practical relevance to developing countries, and suggestions for future research agenda on each of the key topics.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 53 条
[1]   Role of neopterin and 7,8-dihydroneopterin in human immunodeficiency virus infection: Marker for disease progression and pathogenic link [J].
BaierBitterlich, G ;
Wachter, H ;
Fuchs, D .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1996, 13 (02) :184-193
[2]   Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients [J].
Baqui, AAMA ;
Meiller, TF ;
Falkler, WA .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (06) :808-811
[3]   Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes [J].
Baron, S ;
Poast, J ;
Cloyd, MW .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (03) :303-310
[4]   HIV infected women and genital health [J].
Barton, SE .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 1998, 10 (05) :375-378
[5]  
BRANDTZAEG P, 1995, ADV EXP MED BIOL, V371, P201
[6]  
Challacombe S J, 1997, Oral Dis, V3 Suppl 1, pS79
[7]   Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles [J].
Challacombe, SJ ;
Rahman, D ;
OHagan, DT .
VACCINE, 1997, 15 (02) :169-175
[8]   A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1993, 14 (03) :107-110
[9]   IMMUNOGLOBULIN-A (IGA), IGA1, AND IGA2 ANTIBODIES TO CANDIDA-ALBICANS IN WHOLE AND PAROTID-SALIVA IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND AIDS [J].
COOGAN, MM ;
SWEET, SP ;
CHALLACOMBE, SJ .
INFECTION AND IMMUNITY, 1994, 62 (03) :892-896
[10]   SALIVA - ITS SECRETION, COMPOSITION AND FUNCTIONS [J].
EDGAR, WM .
BRITISH DENTAL JOURNAL, 1992, 172 (08) :305-312